Nutrien Ltd.

LSE:0NHS Stock Report

Market Cap: US$27.3b

Nutrien Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

LSE:0NHS Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
12 Sep 25BuyUS$28,541Mark ThompsonIndividual500US$57.08
27 Aug 25BuyUS$9,512Mark ThompsonIndividual163US$58.35
12 Aug 25BuyUS$33,658Andrew KelemenIndividual600US$56.10
08 Aug 25BuyUS$111,094Mark ThompsonIndividual2,000US$55.55
27 Jun 25BuyUS$23,402Mark ThompsonIndividual402US$58.21
25 Jun 25BuyUS$14,486Mark ThompsonIndividual245US$59.13
06 Jun 25BuyUS$17,915Mark ThompsonIndividual300US$59.72
30 May 25BuyUS$50,086Christopher ReynoldsIndividual858US$58.38
09 May 25BuyUS$12,091Mark ThompsonIndividual220US$54.96
09 May 25BuyUS$10,990Andrew KelemenIndividual200US$54.95
31 Mar 25BuyUS$19,809Mark ThompsonIndividual400US$49.52
25 Mar 25BuyUS$25,387Mark ThompsonIndividual500US$50.77
25 Mar 25BuyUS$19,974Mark ThompsonIndividual400US$49.93
11 Mar 25BuyUS$101,780Julie LagacyIndividual2,000US$50.89
05 Mar 25BuyUS$99,260Christopher ReynoldsIndividual2,000US$49.63
04 Mar 25BuyUS$24,179Mark ThompsonIndividual500US$48.41
04 Mar 25BuyUS$48,486Noralee BradleyIndividual1,000US$48.49
03 Mar 25BuyUS$67,392Mark ThompsonIndividual1,350US$49.92
25 Feb 25BuyUS$32,243Rajveer KushwahaIndividual600US$53.78
24 Feb 25BuyUS$260,500Michael HenniganIndividual5,000US$52.10
30 Dec 24BuyUS$41,149Noralee BradleyIndividual930US$44.26
24 Dec 24BuyUS$466,890Kenneth SeitzIndividual10,490US$44.51
19 Nov 24BuyUS$6,825Noralee BradleyIndividual150US$45.50
18 Nov 24BuyUS$22,321Mark ThompsonIndividual490US$45.55
18 Nov 24BuyUS$13,665Noralee BradleyIndividual300US$45.55
18 Nov 24BuyUS$91,119Andrew KelemenIndividual2,000US$45.56
12 Nov 24BuyUS$7,085Noralee BradleyIndividual150US$47.23
08 Nov 24BuyUS$16,026Mark ThompsonIndividual330US$48.60
08 Nov 24BuyUS$28,894Noralee BradleyIndividual600US$48.17

Insider Trading Volume

Insider Buying: 0NHS insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 0NHS?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders189,7450.0391%
State or Government279,3830.0575%
General Public116,864,87624.1%
Institutions368,550,03775.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 48.05% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
5.11%
BlackRock, Inc.
24,820,607US$1.4b622%0.02%
4.51%
The Vanguard Group, Inc.
21,903,308US$1.2b3.36%0.02%
2.85%
BMO Asset Management Corp.
13,859,699US$778.6m-15.1%0.29%
2.73%
First Eagle Investment Management, LLC
13,268,229US$745.3m14%0.79%
2.73%
RBC Global Asset Management Inc.
13,265,201US$745.2m-4.81%0.39%
2.46%
Arrowstreet Capital, Limited Partnership
11,944,730US$671.0m48.5%0.45%
2.44%
RBC Dominion Securities Inc.
11,873,388US$667.0m8.93%0.5%
2.07%
Dodge & Cox
10,076,659US$566.0m-19.1%0.17%
2%
FMR LLC
9,723,473US$546.2m29.6%0.03%
1.71%
1832 Asset Management L.P.
8,320,337US$467.4m-10.7%0.58%
1.61%
Deutsche Asset & Wealth Management
7,826,588US$439.6m29%0.11%
1.6%
Silchester International Investors LLP
7,767,985US$436.4m-27%1.67%
1.51%
Canada Pension Plan Investment Board
7,341,309US$412.4m-16.5%0.22%
1.47%
Mackenzie Financial Corporation
7,129,452US$400.5m-9.24%0.38%
1.43%
Capital Research and Management Company
6,957,911US$390.9m105%0.02%
1.4%
Norges Bank Investment Management
6,789,729US$381.4m25.4%0.03%
1.36%
ARGA Investment Management, LLC
6,592,381US$370.3m1.25%7.74%
1.3%
TD Asset Management, Inc.
6,325,095US$355.3m2.36%0.23%
1.28%
Royal Bank of Canada
6,230,525US$350.0m-45.5%0.16%
1.24%
Beutel Goodman & Company Ltd.
6,001,244US$337.1m-3.57%1.64%
1.12%
Dimensional Fund Advisors LP
5,430,265US$305.0m10.3%0.04%
1.08%
Manulife Asset Management
5,246,421US$294.7m-20%0.21%
1.02%
Canadian Imperial Bank of Commerce
4,962,319US$278.8m-7.67%0.56%
1.01%
The Toronto-Dominion Bank
4,906,900US$275.6m-37%0.33%
1.01%
National Bank Investments Inc.
4,898,939US$275.2m6.09%0.26%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/22 02:49
End of Day Share Price 2025/10/22 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Nutrien Ltd. is covered by 58 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Harriet LiAccountability Research Corporation
Keith CarpenterATB Capital Markets
Peter WardBarclays